Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeles Alvarez Secord

Showing results (171-180 of 239) with videos related to

Pageof 24
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2025
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator ProgramAngeles Alvarez Secord, Ronald D Alvarez, Leslie M Randall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2018
A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic AnalysesDaniela Matei, Sharad Ghamande, Lynda Roman, et al.
Oxidative Medicine and Cellular Longevity|September 3, 2025
Suppression of Paclitaxel-Induced Neuropathy and Ovarian Tumor Growth by Mn Porphyrin, MnTnBuOE-2-PyP<sup>5+</sup> (BMX-001)Ivan Spasojevic, Zhiqing Huang, Welida Tamires Alves da Silva, et al.
Gynecologic Oncology|September 11, 2013
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?Stephanie Ricci, Robert L Giuntoli, Eric Eisenhauer, et al.
Gynecologic Oncology|December 25, 2012
Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancerRabbie K Hanna, Marek S Poniewierski, Robin A Laskey, et al.
Gynecologic Oncology|March 31, 2024
High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell linesXiaochang Shen, Jiandong Wang, Boer Deng, et al.
Gynecologic Oncology|October 12, 2016
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary studyArlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, et al.
Gynecologic Oncology|September 20, 2021
Obesity and altered angiogenic-related gene expression in endometrial cancerLauren Patterson Cobb, Sharareh Siamakpour-Reihani, Dadong Zhang, et al.
Cancer|August 6, 2014
Patient preferences in advanced or recurrent ovarian cancerLaura J Havrilesky, Angeles Alvarez Secord, Jessie A Ehrisman, et al.
JAMA Network Open|May 8, 2024
Sexual Harassment, Abuse, and Discrimination in Obstetrics and Gynecology: A Systematic ReviewAnkita Gupta, Jennifer C Thompson, Nancy E Ringel, et al.
Pageof 24

Showing results (171-180 of 239) with videos related to

Sort By:
Pageof 24
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2025
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator ProgramAngeles Alvarez Secord, Ronald D Alvarez, Leslie M Randall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2018
A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic AnalysesDaniela Matei, Sharad Ghamande, Lynda Roman, et al.
Oxidative Medicine and Cellular Longevity|September 3, 2025
Suppression of Paclitaxel-Induced Neuropathy and Ovarian Tumor Growth by Mn Porphyrin, MnTnBuOE-2-PyP<sup>5+</sup> (BMX-001)Ivan Spasojevic, Zhiqing Huang, Welida Tamires Alves da Silva, et al.
Gynecologic Oncology|September 11, 2013
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?Stephanie Ricci, Robert L Giuntoli, Eric Eisenhauer, et al.
Gynecologic Oncology|December 25, 2012
Predictors of reduced relative dose intensity and its relationship to mortality in women receiving multi-agent chemotherapy for epithelial ovarian cancerRabbie K Hanna, Marek S Poniewierski, Robin A Laskey, et al.
Gynecologic Oncology|March 31, 2024
High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell linesXiaochang Shen, Jiandong Wang, Boer Deng, et al.
Gynecologic Oncology|October 12, 2016
Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary studyArlene E Garcia-Soto, James J Java, Wilberto Nieves Neira, et al.
Gynecologic Oncology|September 20, 2021
Obesity and altered angiogenic-related gene expression in endometrial cancerLauren Patterson Cobb, Sharareh Siamakpour-Reihani, Dadong Zhang, et al.
Cancer|August 6, 2014
Patient preferences in advanced or recurrent ovarian cancerLaura J Havrilesky, Angeles Alvarez Secord, Jessie A Ehrisman, et al.
JAMA Network Open|May 8, 2024
Sexual Harassment, Abuse, and Discrimination in Obstetrics and Gynecology: A Systematic ReviewAnkita Gupta, Jennifer C Thompson, Nancy E Ringel, et al.
Pageof 24